LOS ANGELES, Dec. 1, 2023 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK). Class Period: December 29, 2022 – August 29, 2023 Lead Plaintiff Deadline: January 2, 2024… Continue reading OTLK Investors Have Opportunity to Lead Outlook Therapeutics, Inc. Securities Fraud Lawsuit
Category: Official Press Release
UAE President and King of Malaysia witness Major Step Forward in development of 10GW clean energy projects by Masdar and MIDA
In the presence of UAE President, His Highness Sheikh Mohamed bin Zayed Al Nahyan and the King of Malaysia, His Majesty Al-Sultan Abdullah Sultan Ahmad Shah, Masdar exchanges implementation roadmap with MIDA to advance 10GW of clean energy projects in Malaysia UAE clean energy champion also signs five agreements unlocking up to 8GW of renewable energy… Continue reading UAE President and King of Malaysia witness Major Step Forward in development of 10GW clean energy projects by Masdar and MIDA
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. SPECIAL DISTRIBUTION
NEW YORK, Dec. 1, 2023 /PRNewswire/ — AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF), a closed‑end management investment company, declared on this date, December 1, 2023, a one-time special income distribution of $0.0209 per share of Common Stock. The total distribution of $0.0209 is payable on January 19, 2024 to stockholders of record at… Continue reading ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND, INC. SPECIAL DISTRIBUTION
Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
METRO CHICAGO, Ill., Dec. 1, 2023 /PRNewswire/ — Calamos Investments®* has announced monthly distributions and sources of distributions paid in December 2023 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds’ respective distribution plans. Fund Distribution Payable date Record date Ex-dividend date CHI (inception 06/26/2002) Calamos Convertible Opportunities and Income Fund… Continue reading Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
NKLA Investors Have Opportunity to Lead Nikola Corporation Securities Fraud Lawsuit
Shareholders with losses of $100,000 or more are encouraged to contact the firm. BENSALEM, Pa., Dec. 1, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA). Class Period: February 24,… Continue reading NKLA Investors Have Opportunity to Lead Nikola Corporation Securities Fraud Lawsuit
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 1, 2023 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an aggregate of 31,000 shares of Akebia’s common stock on November 30, 2023, as inducements material to such employee entering… Continue reading Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWTON, Mass., Dec. 1, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 15,700 restricted stock units (RSUs) to three newly-hired employees. These RSU awards were granted as of November 30, 2023 (the “Grant Date”) pursuant to the Company’s… Continue reading Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass., Dec. 1, 2023 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on December 1, 2023 the Company granted inducement awards to purchase up to 158,000 shares of common stock to nine new employees under the Company’s 2023 Inducement Plan. The stock options… Continue reading Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
@FCA: Stellantis Spotlight Wraps the Week
December 1, 2023 , Auburn Hills, Mich. – “Stellantis Spotlight” is a weekly recap of some of the major stories at Stellantis. The top stories for the week ending December 1, 2023, include a hall of fame induction, Green SUV of the Year honors for Alfa Romeo and Mopar reveals its guide to holiday gift-giving. … Continue reading @FCA: Stellantis Spotlight Wraps the Week
@Fisker: Fisker Provides Business Update000179
LOS ANGELES–(BUSINESS WIRE)–Fisker Inc. (NYSE: FSR) (“Fisker”), driven by a mission to create the world’s most emotional and sustainable electric vehicles, today provided a business update for the month of November. Increasing pace of deliveries and sharpening focus on growing current markets The company has executed a new strategy to optimize deliveries in the US… Continue reading @Fisker: Fisker Provides Business Update000179